Antares Pharma Inc (NASDAQ:ATRS)

2.64
BATS BZX Real-Time Price
As of 3:54pm ET
 -0.055 / -2.04%
Today’s Change
1.58
Today|||52-Week Range
4.09
+32.41%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues13.4M15.1M14.0M12.7M
 
 
 
 
 
Cost of Goods Sold5.1M8.0M6.5M6.6M
 
 
 
 
 
Depreciation And Amortization477.8K548.7K583.8K604.0K
 
 
 
 
 
 
Operating ExpensesGross Income7.8M6.5M6.9M5.5M
 
 
 
 
 
General Expenses10.5M11.5M11.0M11.1M
 
 
 
 
 
Research And Development3.2M3.3M3.6M3.3M
 
 
 
 
 
Total Operating Expenses16.1M20.0M18.1M18.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.7M-4.9M-4.0M-5.6M
 
 
 
 
 
Interest Expense On Debt--625.9K628.9K631.0K
 
 
 
 
Other Expenses-120.3K119.2K933.9K57.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.8M-5.5M-3.7M-6.2M
 
 
 
 
 
Net Income-2.8M-5.5M-3.7M-6.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS155.9M156.4M156.7M156.7M
 
 
 
 
 
Shares To Calculate EPS Diluted155.9M156.4M156.7M156.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.02-$0.03-$0.02-$0.04
 
 
 
 
 
EPS Diluted-$0.02-$0.03-$0.02-$0.04